Developed integrated global product strategies to optimize the potential of clinical stage and marketed therapies.
• Led the development and execution of integrated product strategic plans, managing cross-functional collaboration including a focus on internal and external scenarios, to support the C-suite and Board of Directors in effectively communicating market competitiveness and boosting investor confidence.
• Anticipated the evolution of the IgAN marketplace over the next 3-5 years, assessing new entrants / mechanisms of actions (MOAs), and competitive threats, thereby guiding key strategic decisions to safeguard and differentiate the organization's market position.
• Collaborated with the business development team in conducting comprehensive due diligence, furnishing the executive team with pivotal quantitative and qualitative strategic insights to ensure well-informed decision making for molecule / candidate selection.

Served as HCP brand management lead overseeing product strategy and execution for commercial launch.
• Led global team and workstreams to develop brand, strategy, and messages for HCP audience across launch materials: identity, archetyping, IVA, digital marketing / non-personal promotion, market research, contributing to the "most successful launch in BioMarin's history" ($169M in first full year 2022).
• Led cross-functional collaboration as the commercial lead for an early-stage New Molecular Entity (NME) product, influencing key program decisions, and adeptly represented the commercial perspective at core team and executive forums, determining the product's development trajectory and strategic positioning.
• Performed routine development of market sizing, business case development, valuation to support NPV analysis and executive decision making.

Developed and executed global diagnostic strategies to support earlier detection across product portfolio.
• Aligned fragmented diagnostic programs, implemented global KPI aggregation with a PowerBI dashboard, and demonstrated ROI and value propositions, overseeing and providing discipline for >$10M in organizational spend.
• Led roll out of integrated global strategic framework on emerging diagnostic technologies and platforms, created new key SOPs dictating diagnostic workflows, and continually adapted based on market research.

Led commercial launch project management across multiple global, regional, and cross-functional teams.
• Managed the successful launch of 2 therapies (BRINEURA and PALYNZIQ) to global markets (EMA, FDA); collaborated with 14+ functions with 100+ team members across matrixed global and regional teams.
• Created department within commercial organization: developed standardization, tools, and strategic playbook for management of global and regional product launches. Page Two

Delivered strategy and operations management consulting services to the pharma and life science industry.
• Performed due diligence and related financial modeling of business scenarios to assist private equity buyout of a medical device manufacturer ($500M).
• Created a 5-year strategic vision for key business units, forecasting the impact of emerging technologies (social media, big data, mobile health) on future workflows, enhancing organizational adaptability and sustained competitiveness.
• Right sized field inventory (-25%) through statistical modeling, proposed customer segmentation and service level application, and detailed improvements during product forecasting and deployment during introduction (launch) campaigns.
● Additional Relevant Experience